322 related articles for article (PubMed ID: 31145701)
1. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
3. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
4. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
[TBL] [Abstract][Full Text] [Related]
5. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
6. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
Li P; Busam KJ
J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
[TBL] [Abstract][Full Text] [Related]
7. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
8. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
[TBL] [Abstract][Full Text] [Related]
9. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
[TBL] [Abstract][Full Text] [Related]
10. Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.
Kervarrec T; Pissaloux D; Paindavoine S; Tirode F; Osio A; Mourah S; Jouenne F; Sohier P; Calonje E; Pekar A; Luna EVE; Goto K; Delalande F; Frouin E; Macagno N; Drouot F; Faisan M; Cribier B; Battistella M; de la Fouchardière A
Histopathology; 2023 Aug; 83(2):310-319. PubMed ID: 37199682
[TBL] [Abstract][Full Text] [Related]
11. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
12. YAP1::MAML2 fusions in poromatosis: A report of two patients.
Mitsui Y; Ogawa K; Goto K; Fujii T; Nakamura-Nishimura Y; Mashiba K; Asada H
J Cutan Pathol; 2023 Aug; 50(8):695-701. PubMed ID: 36723803
[TBL] [Abstract][Full Text] [Related]
13. YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
Agaimy A; Stoehr R; Tögel L; Hartmann A; Cramer T
Head Neck Pathol; 2021 Mar; 15(1):361-367. PubMed ID: 32504288
[TBL] [Abstract][Full Text] [Related]
14. Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement.
Wang X; Liu LL; Li Q; Xia QY; Li R; Ye SB; Zhang RS; Fang R; Chen H; Wu N; Rao Q
Histopathology; 2023 Nov; 83(5):798-809. PubMed ID: 37565303
[TBL] [Abstract][Full Text] [Related]
15. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
Christensen DJ; Tuluc M
J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
[TBL] [Abstract][Full Text] [Related]
16. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
[TBL] [Abstract][Full Text] [Related]
17. Fusion-positive skin/adnexal carcinomas.
Agaimy A
Genes Chromosomes Cancer; 2022 May; 61(5):274-284. PubMed ID: 35167714
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.
Szulzewsky F; Arora S; Hoellerbauer P; King C; Nathan E; Chan M; Cimino PJ; Ozawa T; Kawauchi D; Pajtler KW; Gilbertson RJ; Paddison PJ; Vasioukhin V; Gujral TS; Holland EC
Genes Dev; 2020 Aug; 34(15-16):1051-1064. PubMed ID: 32675324
[TBL] [Abstract][Full Text] [Related]
19. Cuticular Poroma: A Rare Poroma Variant Simulating a Malignant Neoplasm That Often Harbors YAP1::NUTM1 Fusions Similar to Their Conventional Counterparts.
Kolm I; Konstantinova AM; Kutzner H; Barghorn A; Vanecek T; Mangana J; Kazakov DV
Am J Dermatopathol; 2023 Aug; 45(8):544-548. PubMed ID: 37335840
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
